08:55 AM EST, 11/24/2025 (MT Newswires) -- Health care stocks were advancing premarket Monday, with The Health Care Select Sector SPDR Fund (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) 0.4% higher.

Novo Nordisk ( NVO ) stock was down more than 9% after the company said its weight-loss drug semaglutide failed to meet its primary endpoint of reducing Alzheimer's progression in two phase 3 trials enrolling a total of 3,808 adults.